The Market Research on Enteral Feeding Formulas, By Considering useful aspects like; Material, Product, Application, End User (Hospital, ASCs) - Global Future Forecast till 2020, published by MarketsandMarkets™, the report studies the global Enteral Feeding Formulas market over the forecast period of 2017 to 2020. The market is projected to reach USD 5.95 Billion by 2020 at a CAGR of 7.6%.
Enteral Feeding Formulas Market by Product (Polymeric, Monomeric, Disease-Specific Formulas), by Stage (Adults, Pediatrics), by Application (Oncology, Gastroenterology, Neurology), by End User (Hospitals, LTCS, Home Care) - Global Forecast to 2020
Geographically, the market in North America and Europe is growing at a significant rate owing to the rising geriatric population along with increasing incidences of chronic diseases and disorders, increasing healthcare expenditure, and increasing demand for homecare in these regions. The Asia-Pacific region however is expected to become the growth center for the enteral feeding formulas market. The market in Japan, China, and India is likely to witness significant growth during the forecast period, owing to the presence of a large patient pool for chronic diseases and disorders, high incidences of preterm births, growing healthcare expenditure, rapidly developing healthcare infrastructure, increasing per capita income, growing middle-class population, and growing population in these countries.
In 2015, the major players in the global enteral feeding formulas market accounted for more than half of the market share. To maintain their market shares, major players focus on new product launches expansions, partnerships, agreements, and collaboration and acquisitions as key growth strategies. Of all these strategies, new product launches and expansions were the key strategies adopted by the major market players in 2015.
Based on application, the market is segmented into oncology, gastroenterology, neurology, diabetes, critical care, and other applications. Other applications primarily include diseases and disorders of the heart, renal system, lungs, and liver, along with psychiatric disorders. The oncology application segment held the largest share of the enteral feeding formulas market in 2015, primarily due to high prevalence of malnutrition among cancer patients.

Future Scope of the enteral feeding formulas:
Enteral feeding formulas are nutritional replacement products that assist in the nutritive and metabolic processes of the body, to maintain adequate weight and strength corresponding to the overall health status of an individual. These formulas are extensively used in hospitals and long-term care facilities. Based on product type, enteral feeding formulas are classified as standard formulas and disease-specific formulas.


The Enteral Feeding Formulas market is fragmented with the presence of emerging players;

Abbott Laboratories (U.S.)
Nestlé S.A. (Switzerland)
Danone S.A. (France)
Fresenius Kabi AG (Germany)
Mead Johnson Nutrition Company (U.S.)
B. Braun Melsungen AG (Germany)…..Read More

Request a Sample Copy of "Enteral Feeding Formulas Market" Consist 187 tables and 72 figures spread over 219 pages and in-depth TOC: https://www.marketsandmarkets.com/requestsample.asp?id=74876393

Global Enteral Feeding Formulas Market, by Product
1. Standard Formulas
a. Polymeric Formulas
b. Monomeric Formulas
Global Enteral Feeding Formulas Market, by Stage
• Adults
• Pediatrics
Global Enteral feeding formulas Market, by Application
• Oncology
• Gastroenterology
• Neurology
Global Enteral feeding formulas Market, by End User
• Hospitals
• Long-term Care Facilities
Enteral Feeding Formulas Market, by Region;
North America (US, Canada)
Europe (UK, Germany, Others)
Asia
Rest of the World

For any queries Speak to our Analyst:
https://www.marketsandmarkets.com/speaktoanalyst.asp?id=74876393

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownload.asp?id=74876393